SynthesisInflammopharmacology2026
Effects of curcumin on inflammatory and oxidative stress related markers in rat models of experimental arthritis: a systematic review and meta-analysis.
Synthesis in Inflammopharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThis study evaluated whether orally administered pure curcumin affects inflammatory cytokines and oxidative stress-related markers in rat models of experimental arthritis.
methodsWe searched Web of Science, PubMed, Embase and Scopus for studies published up to June 2026. Studies used rat models of experimental arthritis, compared orally administered pure curcumin with vehicle or untreated controls, and reported inflammatory or oxidative stress-related outcomes. Model selection was based on heterogeneity: fixed-effect analyses were performed for outcomes with I² values of 50% or lower, while random-effects analyses were conducted when I² exceeded 50%.
resultsTen studies were eligible for inclusion. Compared with control conditions, curcumin administration was associated with decreases in IL-1β (SMD = - 2.91, 95% CI: -3.59 to - 2.22) and TNF-α (SMD = - 1.50, 95% CI: -1.97 to - 1.04), while IL-10 levels were increased (SMD = 1.23, 95% CI: 0.34 to 2.13). Curcumin also improved oxidative stress-related profiles, with higher levels of SOD (SMD = 1.13, 95% CI: 0.12 to 2.15), GSH (SMD = 1.48, 95% CI: 0.65 to 2.30), CAT (SMD = 1.57, 95% CI: 0.47 to 2.66), and GPx (SMD = 2.94, 95% CI: 0.54 to 5.35), and lower LPO levels (SMD = - 0.94, 95% CI: -1.56 to - 0.32). Sensitivity analyses supported the direction of the findings.
conclusionOrally administered pure curcumin was associated with favorable changes in inflammatory and oxidative stress-related markers in rat models of experimental arthritis. These findings warrant further well-designed animal studies using standardized methods and clinically relevant structural, functional, and safety outcomes.
Indexed as
Identifiers
42573968What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.